Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 September 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 189 pages)

 

Export 16 results:
Author Title Type [ Year(Asc)]
Filters: Author is Schlienger, R. G.  [Clear All Filters]
2016
C. Huerta, Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., Miret, M., Schneider, C., Gil, M., Souverein, P. C., De Bruin, M. L., Slattery, J., de Groot, M. C., Hesse, U., Rottenkolber, M., Schmiedl, S., Montero, D., Bate, A., Ruigomez, A., Garcia-Rodriguez, L. A., Johansson, S., de Vries, F., Schlienger, R. G., Reynolds, R. F., Klungel, O. H., and de Abajo, F. J., “Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 56-65, 2016.
2014
V. Abbing-Karahagopian, Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., Alvarez, Y., Miret, M., Gil, M., Oliva, B., Hesse, U., Requena, G., de Vries, F., Rottenkolber, M., Schmiedl, S., Reynolds, R., Schlienger, R. G., de Groot, M. C., Klungel, O. H., van Staa, T. P., van Dijk, L., Egberts, A. C., Gardarsdottir, H., and De Bruin, M. L., “Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications”, Eur J Clin Pharmacol, vol. 70, pp. 849-57, 2014.
S. G. Bruderer, Bodmer, M., Jick, S. S., Bader, G., Schlienger, R. G., and Meier, C. R., “Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK–a nested case-control analysis”, Diabetes Obes Metab, vol. 16, pp. 801-11, 2014.
2007
R. G. Schlienger, Fedson, D. S., Jick, S. S., Jick, H., and Meier, C. R., “Statins and the risk of pneumonia: a population-based, nested case-control study”, Pharmacotherapy, vol. 27, pp. 325-32, 2007.
2005
L. M. Fischer, Schlienger, R. G., Matter, C. M., Jick, H., and Meier, C. R., “Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction”, Pharmacotherapy, vol. 25, pp. 503-10, 2005.
2004
R. G. Schlienger, Fischer, L. M., Jick, H., and Meier, C. R., “Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction”, Drug Saf, vol. 27, pp. 1157-65, 2004.
L. M. Fischer, Schlienger, R. G., Matter, C. M., Jick, H., and Meier, C. R., “Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction”, Arch Intern Med, vol. 164, pp. 2472-6, 2004.
L. M. Fischer, Schlienger, R. G., Matter, C., Jick, H., and Meier, C. R., “Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction”, Am J Cardiol, vol. 93, pp. 198-200, 2004.
R. G. Schlienger, Jick, S. S., and Meier, C. R., “Inhaled corticosteroids and the risk of fractures in children and adolescents”, Pediatrics, vol. 114, pp. 469-73, 2004.
R. G. Schlienger, Kraenzlin, M. E., Jick, S. S., and Meier, C. R., “Use of beta-blockers and risk of fractures”, Jama, vol. 292, pp. 1326-32, 2004.
2003
S. S. Jick, Kaye, J. A., Vasilakis-Scaramozza, C., Rodriguez, L. A. Garcia, Ruigomez, A., Meier, C. R., Schlienger, R. G., Black, C., and Jick, H., “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
2002
C. R. Meier, Krahenbuhl, S., Schlienger, R. G., and Jick, H., “Association between body mass index and liver disorders: an epidemiological study”, J Hepatol, vol. 37, pp. 741-7, 2002.
R. G. Schlienger, Jick, H., and Meier, C. R., “Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction”, Br J Clin Pharmacol, vol. 54, pp. 327-32, 2002.
2001
R. G. Schlienger, Haefeli, W. E., Jick, H., and Meier, C. R., “Risk of cataract in patients treated with statins”, Arch Intern Med, vol. 161, pp. 2021-6, 2001.
C. R. Meier, Schlienger, R. G., and Jick, H., “Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction”, Br J Clin Pharmacol, vol. 52, pp. 179-84, 2001.
2000
C. R. Meier, Schlienger, R. G., Kraenzlin, M. E., Schlegel, B., and Jick, H., “HMG-CoA reductase inhibitors and the risk of fractures”, Jama, vol. 283, pp. 3205-10, 2000.
[Page last reviewed 6 September 2019]